[PLX] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -6.59%
YoY- 31.44%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 21,646 17,759 14,248 12,247 10,439 27,018 663 919.34%
PBT 1,667 291 -3,560 -7,743 -7,264 9,781 -15,544 -
Tax 203 180 34 3 190 99 230 -7.98%
NP 1,667 291 -3,560 -7,743 -7,264 9,781 -15,544 -
Tax Rate -12.18% -61.86% - - - -1.01% - -
Total Cost 19,979 17,468 17,808 19,990 17,703 17,237 16,207 14.95%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 7.70 1.64 -24.99 -63.22 -69.59 36.20 -2,344.49 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS 0.10 0.02 -0.24 -0.52 -0.49 0.66 -1.05 -
EPS Diluted 0.10 0.02 -0.24 -0.52 -0.49 0.66 -1.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.